OpenVSafe by OpenVAERS
Search V-safe

4EM-21109-09912

3 vaccinations 7 coded responses 13 check-ins 7 free-text entries 2 call cases
Sex
Female
Age at first dose
36-40
ZIP prefix
534 / WI
Registered
2021-07-25
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-04-03
    Dose 1 — Pfizer-BioNTech
  2. 2021-04-24
    Dose 2 — Pfizer-BioNTech
  3. 2021-07-25
    Registered in v-safe
  4. 2021-07-25
    Health check-in — 3 months, dose 2
    Feeling: Fair
    Adult check-in
  5. 2021-10-23
    Health check-in — 6 months, dose 2
    Feeling: Fair
    Adult check-in
  6. 2021-11-03
    Dose 3 — Pfizer-BioNTech
  7. 2021-11-04
    Survey response — days 1–6 daily, dose 3
    MedDRA: Oropharyngeal pain, Pre-existing disease, Rhinorrhoea — Feeling: Poor · Site: Pain, Redness, Swelling · Fever · Chills, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activities
    Free text: Sore throat & runny nose developed later in day today. Health condition: Lupus SLE & chronic migraine
    MedDRA releases: 2024-11 · check-in free text available
  8. 2021-11-05
    Survey response — days 1–6 daily, dose 3
    MedDRA: Adverse reaction — Feeling: Fair · Site: Pain, Redness, Swelling · Fever · Chills, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities
    Free text: Symptoms improved significantly throughout day
    MedDRA releases: 2024-11 · check-in free text available
  9. 2021-11-06
    Survey response — days 1–6 daily, dose 3
    MedDRA: Pre-existing disease — Feeling: Good · Site: Pain, Redness · Fatigue or tiredness, Diarrhea
    Free text: Health condition: Lupus SLE
    MedDRA releases: 2024-11 · check-in free text available
  10. 2021-11-07
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · Site: Pain · None
    Adult check-in
  11. 2021-11-20
    Health check-in — day 14, dose 3
    Feeling: Fair
    Adult check-in
  12. 2021-11-24
    Health check-in — day 21, dose 3
    Feeling: Good
    Adult check-in
  13. 2021-12-01
    Survey response — day 28, dose 3
    MedDRA: Cough, Exposure to SARS-CoV-2, Gastrointestinal disorder, Headache, Myalgia, Oropharyngeal pain, Parosmia, Pyrexia, Rash — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: Fever, cough, sore throat, phantom smells, headache, muscle aches, intestinal issues, rash. Exposure to positive COVID19 case; my test was negative though.
    MedDRA releases: 2024-11 · check-in free text available
  14. 2021-12-10
    Survey response — day 35, dose 3
    MedDRA: Fatigue, Fibromyalgia, Myalgia — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Increased fatigue and muscle pain. Diagnosed with fibromyalgia.
    MedDRA releases: 2024-11 · check-in free text available
  15. 2021-12-10
    Report sent to call center — day 35, dose 3
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Outpatient clinic or urgent care clinic visit · 1 call case(s)
  16. 2021-12-14
  17. 2021-12-15
    Survey response — day 42, dose 3
    MedDRA: Cough, Dizziness, Exposure to SARS-CoV-2, Headache, Hypoaesthesia, Myalgia, Rhinorrhoea — Feeling: Poor · Be unable to do your normal daily activities
    Free text: Dizzy, cough, runny nose, headache, muscle aches, numbness, cough. 3 people in my home have tested positive for COVID. Probably have it too.
    MedDRA releases: 2024-11 · check-in free text available
  18. 2022-02-05
    Health check-in — 3 months, dose 3
    Feeling: Fair
    Adult check-in
  19. 2022-11-06
    Survey response — 12 months, dose 3
    MedDRA: Pre-existing disease — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit
    Free text: Chronic hives of unknown origin
    MedDRA releases: 2024-11 · check-in free text available
  20. 2022-11-06
    Report sent to call center — 12 months, dose 3
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Telehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
  21. 2022-11-07
  22. 2022-11-07

Vaccinations

DoseDateManufacturerCo-administered
12021-04-03Pfizer-BioNTech No
22021-04-24Pfizer-BioNTech No
32021-11-03Pfizer-BioNTech No

Call center

2 call center cases

2 unsuccessful

See the call center timeline

Free text

Release 10 — days 1–6 daily, dose 3

2021-11-04

Systemic reaction (other): Sore throat & runny nose developed later in day today. Health condition: Lupus SLE & chronic migraine

2021-11-05

Systemic reaction (other): Symptoms improved significantly throughout day

2021-11-06

Systemic reaction (other): Health condition: Lupus SLE

Release 10 — day 28, dose 3

2021-12-01

Symptoms: Fever, cough, sore throat, phantom smells, headache, muscle aches, intestinal issues, rash. Exposure to positive COVID19 case; my test was negative though.

Release 10 — day 35, dose 3

2021-12-10

Symptoms: Increased fatigue and muscle pain. Diagnosed with fibromyalgia.

Release 10 — day 42, dose 3

2021-12-15

Symptoms: Dizzy, cough, runny nose, headache, muscle aches, numbness, cough. 3 people in my home have tested positive for COVID. Probably have it too.

Release 12 — 12 months, dose 3

2022-11-06

Symptoms: Chronic hives of unknown origin

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDCough · · ✓
SDDizziness · · ✓
SDExposure to SARS-CoV-2 · · ✓
SDFatigue · · ✓
SDFibromyalgia · · ✓
SDGastrointestinal disorder · · ✓
SDHeadache · · ✓
SDHypoaesthesia · · ✓
SDMyalgia · · ✓
SDOropharyngeal pain · · ✓
SDParosmia · · ✓
SDPre-existing disease · · ✓
SDPyrexia · · ✓
SDRash · · ✓
SDRhinorrhoea · · ✓
SROAdverse reaction · · ✓
SROOropharyngeal pain · · ✓
SROPre-existing disease · · ✓
SRORhinorrhoea · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release